Testing effectiveness (Phase 2)Active Not RecruitingNCT03775096
What this trial is testing
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)
Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Michele Tagliati, MD 15